Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide + Fulvestrant in CDK4/6i-Resistant Advanced Breast Cancer
NCT05191914Phase 4Unknown
- Sponsor
- Liaoning Medical Center
- Start
- Feb 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tucidinostat in breast cancer, sponsored by Liaoning Medical Center. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05191914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05191914.